Aspira Pathlab Diagnostics Ltd vs Broach Lifecare Hospital Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Aspira Pathlab & Diagnostics Ltd is ₹ 143.34 as of 29 Sep 10:20 . The P/E Ratio of Aspira Pathlab & Diagnostics Ltd is 0 as of March 2024 .The P/E Ratio of Broach Lifecare Hospital Ltd is 0 as of March 2024 . The Market Cap of Aspira Pathlab & Diagnostics Ltd is ₹ 31.91 crore as of March 2024 .The Market Cap of Broach Lifecare Hospital Ltd is ₹ 0 crore as of March 2024 . The revenue of Aspira Pathlab & Diagnostics Ltd for the Jun '25 is ₹ 5.36 crore as compare to the Mar '25 revenue of ₹ 5.91 crore. This represent the decline of -9.31% The revenue of Broach Lifecare Hospital Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Aspira Pathlab & Diagnostics Ltd for the Jun '25 is ₹ 0.79 crore as compare to the Mar '25 ebitda of ₹ 1.05 crore. This represent the decline of -24.76% The ebitda of Broach Lifecare Hospital Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Aspira Pathlab & Diagnostics Ltd changed from ₹ 0.05 crore to ₹ 0.42 crore over 5 quarters. This represents a CAGR of 448.81% The net profit of Broach Lifecare Hospital Ltd changed from ₹ 0 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of 0.0% The Dividend Payout of Aspira Pathlab & Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Broach Lifecare Hospital Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab & Diagnostics Limited (ASDL) was incorporated in July, 1973.
ASDL is a leading pathology specialist, with Pan-India presence.
It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses.
The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services. Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers.
Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai. ASDL ideology is founded on technological supremacy, patient centric approach, and dependable diagnostic results.

About Broach Lifecare Hospital Ltd

Broach Lifecare Hospital Limited was incorporated as 'Broach Lifecare Hospital Private Limited' dated April 25, 2023, with the Registrar of Companies, Central Registration Centre.
Further, in accordance with the main objects, the Company acquired the sole proprietorship concerns of Dr. Jaykumar Narendra Vyas, the Promoter comprising of the Hospitals i.e.
Dr. Vyas's Heart Hospital and Dr. Vyas Hospital pursuant to a Business Transfer Agreement date July 17, 2023.
Thereafter, the Company was converted into a public limited Company and the name was changed to Broach Lifecare Hospital Limited' dated November 7, 2023 at ROC, Ahmedabad. The Company operates boutique Hospitals under the brand 'Maple Hospitals' and provides dedicated round-the-clock services to patients with heart ailments consisting of non-invasive cardiology services such as, 2D Echocardiography, Electrocardiography, Tread Mill Test, Holter monitoring, Ambulatory Blood Pressure Measurement, Stress test, Dobutamine Stress Echocardiography in June 2023, the Company ventured into interventional cardiac services such as, coronary angiography and stenting, percutaneous coronary intervention (PCI) and primary PCI for acute myocardial infarction as a division.

FAQs for the comparison of Aspira Pathlab & Diagnostics Ltd and Broach Lifecare Hospital Ltd

Which company has a larger market capitalization, Aspira Pathlab & Diagnostics Ltd or Broach Lifecare Hospital Ltd?

Market cap of Aspira Pathlab & Diagnostics Ltd is 129 Cr while Market cap of Broach Lifecare Hospital Ltd is 8 Cr

What are the key factors driving the stock performance of Aspira Pathlab & Diagnostics Ltd and Broach Lifecare Hospital Ltd?

The stock performance of Aspira Pathlab & Diagnostics Ltd and Broach Lifecare Hospital Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aspira Pathlab & Diagnostics Ltd and Broach Lifecare Hospital Ltd?

As of October 24, 2026, the Aspira Pathlab & Diagnostics Ltd stock price is INR ₹126.05. On the other hand, Broach Lifecare Hospital Ltd stock price is INR ₹14.0.

How do dividend payouts of Aspira Pathlab & Diagnostics Ltd and Broach Lifecare Hospital Ltd compare?

To compare the dividend payouts of Aspira Pathlab & Diagnostics Ltd and Broach Lifecare Hospital Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.